Literature DB >> 9595229

Quality of life following esophagectomy with three-field lymphadenectomy for carcinoma, focusing on its relationship to vocal cord palsy.

M Baba1, T Aikou, S Natsugoe, C Kusano, M Shimada, S Nakano, T Fukumoto, H Yoshinaka.   

Abstract

To clarify the quality of life of patients who underwent esophagectomy for carcinoma by right thoracotomy, laparotomy and cervical anastomosis, 116 patients who were cancer free at the time of mailing a questionnaire were analyzed. A significant decrease in vital capacity for 3 years postoperatively, as well as in the percentage of ideal body weight, between 3 and 5 years were observed in 57 patients with three-field lymphadenectomy. Patients' quality of life undergoing three-field dissection was worse than those with less radical lymphadenectomy (59 cases) in terms of the performance status and difficulty in talking at 60 months or more postoperatively. Around 20% of all patients reported severe hoarseness due to permanent recurrent nerve paralysis, resulting in poor quantity of food intake at 24 months or less postoperatively and restricted daily activity and difficulty in talking at 60 months or more after the operation. When a patient suffers from vocal cord insufficiency caused by permanent paralysis of the recurrent nerve, early treatment before discharge from the hospital should be performed to improve the quality of life of such a patient.

Entities:  

Mesh:

Year:  1998        PMID: 9595229

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  9 in total

Review 1.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

2.  Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer.

Authors:  Shoji Natsugoe; Masataka Matsumoto; Hiroshi Okumura; Yasuto Uchikado; Tetsuro Setoyama; Ken Sasaki; Toshihide Sakurai; Itaru Omoto; Tetsuhiro Owaki; Hiroyuki Shinchi; Shinichi Ueno; Sumiya Ishigami
Journal:  Langenbecks Arch Surg       Date:  2010-02-21       Impact factor: 3.445

3.  Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes.

Authors:  Koichi Suda; Yoshinori Ishida; Yuichiro Kawamura; Kazuki Inaba; Seiichiro Kanaya; Satoshi Teramukai; Seiji Satoh; Ichiro Uyama
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

4.  Esophagectomy without mortality: what can surgeons do?

Authors:  Simon Law
Journal:  J Gastrointest Surg       Date:  2009-09-23       Impact factor: 3.452

5.  Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus.

Authors:  Masaru Morita; Akinori Egashira; Rintaro Yoshida; Keisuke Ikeda; Kippei Ohgaki; Kotaro Shibahara; Eiji Oki; Noriaki Sadanaga; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

6.  Postoperative gastrointestinal dysfunction after 2-field versus 3-field lymph node dissection in patients with esophageal cancer.

Authors:  Misuzu Nakamura; Yoshihiro Kido; Yoshinori Hosoya; Masahiko Yano; Hideo Nagai; Morito Monden
Journal:  Surg Today       Date:  2007-04-30       Impact factor: 2.549

7.  CEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma.

Authors:  Wenpeng Jiang; Zhou Wang; Yang Jia
Journal:  Oncol Lett       Date:  2016-11-22       Impact factor: 2.967

8.  Analysis of the associated factors for severe weight loss after minimally invasive McKeown esophagectomy.

Authors:  Peiyu Wang; Yin Li; Haibo Sun; Ruixiang Zhang; Xianben Liu; Shilei Liu; Zongfei Wang; Yan Zheng; Yongkui Yu; Xiankai Chen; Haomiao Li; Jun Zhang; Qi Liu
Journal:  Thorac Cancer       Date:  2018-12-21       Impact factor: 3.500

Review 9.  Ansa cervicalis: a comprehensive review of its anatomy, variations, pathology, and surgical applications.

Authors:  Shogo Kikuta; Skyler Jenkins; Jingo Kusukawa; Joe Iwanaga; Marios Loukas; R Shane Tubbs
Journal:  Anat Cell Biol       Date:  2019-08-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.